Cracking the Blood-Brain Barrier Code: Rational Nanomaterial Design for Next-Generation Neurological Therapies

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Neuroscience

Background:

• The blood-brain barrier (BBB) presents a significant obstacle for delivering therapeutics to the brain.
• Nanoparticles offer potential for targeted drug delivery but face challenges in crossing the BBB.

Purpose of the Study:

• To establish a mechanistic framework for designing nanoparticles that can efficiently cross the BBB.
• To provide quantitative design windows and translational guidance for nanoparticle development for brain targeting.

Main Methods:

• Systematic analysis of nanoparticle-BBB transport mechanisms (receptor-mediated transcytosis, adsorptive-mediated transcytosis, barrier modulation).
• Evaluation of nanoparticle parameters (size, shape, charge, etc.) and preclinical models for brain targeting efficacy.
• Integration of regulatory and toxicology considerations into design checklists.

Main Results:

• Quantitative 'design windows' for nanoparticles (size 10-100 nm, aspect ratio ~2-5, near-neutral ζ) were derived for efficient transcytosis.
• A translational decision guide was developed by cross-walking human-relevant in vitro/in vivo models.
• Recent brain uptake data (%ID/g) for various nanoparticle vectors (2020-2025) were curated.

Conclusions:

• This review provides actionable, evidence-based rules for designing nanoparticles to overcome the BBB.
• The framework aids in optimizing nanoparticle properties and selecting appropriate models for preclinical development.
• Integrating design, modeling, and regulatory aspects facilitates translation of nanotherapeutics for neurological disorders.